TALEN

TALEN1-hmox1a

ID
ZDB-TALEN-231006-1
Name
TALEN1-hmox1a
Previous Names
None
Target
Target Sequence 1
5' - TCTGTTTTTTTAGAGA - 3'
Target Sequence 2
5' - TGTTCTCTGCCGCTTT - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
None
Genome Resources
None
Target Location
Constructs
No data available
Genomic Features
Genomic Feature Affected Genomic Regions
vcc42 hmox1a
Expression
Gene expression in Wild Types + TALEN1-hmox1a
No data available
Phenotype
Phenotype resulting from TALEN1-hmox1a
No data available
Phenotype of all Fish created by or utilizing TALEN1-hmox1a
Phenotype Fish Conditions Figures
trunk pyogenic granuloma loose, abnormal hmox1avcc42/vcc42 bacterial treatment by injection: Mycobacterium marinum Fig. 2 from Luo et al., 2021
response to bacterium decreased process quality, abnormal hmox1avcc42/vcc42 bacterial treatment by injection: Mycobacterium marinum Fig. 2 from Luo et al., 2021
whole organism viability, exacerbated hmox1avcc42/vcc42 bacterial treatment by injection: Mycobacterium marinum Fig. 2 from Luo et al., 2021
whole organism viability, abnormal hmox1avcc42/vcc42 bacterial treatment by injection: Escherichia coli Fig. 3 from Luo et al., 2021
whole organism viability, abnormal hmox1avcc42/vcc42 bacterial treatment by injection: Mycobacterium marinum Fig. 3 from Luo et al., 2021
intracellular iron ion homeostasis decreased process quality, abnormal hmox1avcc42/vcc42 bacterial treatment by injection: Mycobacterium marinum Fig. 4 from Luo et al., 2021
trunk pyogenic granuloma organized, abnormal hmox1avcc42/vcc42 bacterial treatment by injection: Mycobacterium marinum Fig. 2 from Luo et al., 2021
whole organism aco1 expression decreased amount, abnormal hmox1avcc42/vcc42 bacterial treatment by injection: Mycobacterium marinum Fig. 4 from Luo et al., 2021
whole organism hmox2a expression increased amount, abnormal hmox1avcc42/vcc42 (AB/TU) standard conditions Fig. 4 from Luo et al., 2022
whole organism decreased length, abnormal hmox1avcc42/vcc42 (AB/TU) standard conditions Fig. 3 from Luo et al., 2022
whole organism deformed, abnormal hmox1avcc42/vcc42 (AB/TU) standard conditions Fig. 3 from Luo et al., 2022
whole organism viability, abnormal hmox1avcc42/vcc42 (AB/TU) standard conditions Fig. 3 from Luo et al., 2022
whole organism deformed, abnormal hmox1avcc42/vcc42 (AB/TU) standard conditions Fig. 3 from Luo et al., 2022
whole organism deformed, abnormal hmox1avcc42/vcc42 (AB/TU) standard conditions Fig. 3 from Luo et al., 2022
whole organism hmox2b expression increased amount, abnormal hmox1avcc42/vcc42 (AB/TU) standard conditions Fig. 4 from Luo et al., 2022
whole organism hmox1b expression increased amount, abnormal hmox1avcc42/vcc42 (AB/TU) standard conditions Fig. 4 from Luo et al., 2022
whole organism viability, exacerbated hmox1avcc42/+ bacterial treatment by injection: Mycobacterium marinum Fig. 2 from Luo et al., 2021
whole organism ccr2 expression increased amount, abnormal hmox1avcc42/vcc42; vcc7Tg (AB/TU) amputation: post-vent region Fig. 5 from Luo et al., 2022
whole organism mcp1 expression decreased amount, abnormal hmox1avcc42/vcc42; vcc7Tg (AB/TU) amputation: post-vent region Fig. 5 from Luo et al., 2022
post-vent region macrophage decreased distribution, abnormal hmox1avcc42/vcc42; vcc7Tg (AB/TU) amputation: post-vent region Fig. 5 from Luo et al., 2022
Citations